FRSH(FRSH)
FRSH
Q4 2026 EPS Estimate
$0.18
Nov 3, 2026 · Reports after close
Revenue Estimate
$245M
FY2026E EPS$0.67
FY2027E EPS$0.83
Analyst Sentiment
Wall St. Consensus
Buy17 analysts·Moderate coverage
63
Score
9 Buy (53%)8 Hold (47%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
953%
Hold
847%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$8.00
-38.6%
Consensus
$13.00
-0.2%
Bull
$15.00
+15.2%
12-Month Target Range17 analysts
$8.00$13.00$15.00
Current $13.02Consensus
Current Price
$13.02
Above Consensus
$0.02
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+14.20%
EPS+24.53%
FY2028
Rev+15.55%
EPS+18.99%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $965M | $1.10B | $1.27B |
| Low | $965M | $1.09B | $1.24B |
| High | $965M | $1.11B | $1.31B |
| EBITDA Avg | $516M | $589M | $680M |
| Low | $516M | $585M | $665M |
| High | $516M | $594M | $698M |
| EBIT Avg | $451M | $515M | $596M |
| Low | $451M | $512M | $582M |
| High | $451M | $520M | $611M |
| Net Income Avg | $196M | $242M | $291M |
| Low | $194M | $233M | $279M |
| High | $199M | $251M | $303M |
| EPS Avg | $0.67 | $0.83 | $0.99 |
| Low | $0.66 | $0.79 | $0.95 |
| High | $0.68 | $0.85 | $1.03 |
| Analysts (Rev / EPS) | 12 / 9 | 12 / 9 | 9 / 3 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $245M | $254M | $261M | $270M | $280M | $291M | $300M | $311M |
| Low | $245M | $254M | $261M | $270M | $279M | $290M | $300M | $311M |
| High | $245M | $254M | $261M | $271M | $280M | $291M | $300M | $311M |
| EBITDA Avg | $131M | $136M | $140M | $145M | $149M | $155M | $160M | $166M |
| Low | $131M | $136M | $139M | $144M | $149M | $155M | $160M | $166M |
| High | $131M | $136M | $140M | $145M | $150M | $155M | $160M | $166M |
| EBIT Avg | $115M | $119M | $122M | $127M | $131M | $136M | $140M | $146M |
| Low | $115M | $119M | $122M | $126M | $131M | $136M | $140M | $145M |
| High | $115M | $119M | $122M | $127M | $131M | $136M | $140M | $146M |
| Net Income Avg | $49M | $57M | $48M | $56M | $59M | $65M | $58M | $66M |
| Low | $49M | $54M | $48M | $56M | $59M | $65M | $58M | $66M |
| High | $49M | $57M | $49M | $56M | $59M | $65M | $58M | $67M |
| EPS Avg | $0.18 | $0.21 | $0.18 | $0.20 | $0.22 | $0.24 | $0.21 | $0.24 |
| Low | $0.18 | $0.20 | $0.18 | $0.20 | $0.22 | $0.24 | $0.21 | $0.24 |
| High | $0.18 | $0.21 | $0.18 | $0.20 | $0.22 | $0.24 | $0.21 | $0.24 |
| Analysts (Rev / EPS) | 9 / 10 | 9 / 10 | 7 / 8 | 4 / 8 | 4 / 8 | 7 / 8 | 7 / 9 | 3 / 9 |